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Abstract
The generation of reactive oxygen species (ROS) is required for
proper cell signaling, but must be tightly regulated to minimize
deleterious oxidizing effects. Activation of the NADPH oxidases
(Nox) triggers ROS production and, thus, regulatory mechanisms
exist to properly control Nox activity. In this study, we report a
novel mechanism in which Nox1 activity is regulated through the
proteasomal degradation of Nox organizer 1 (NoxO1). We found
that through the interaction between NoxO1 and growth recep-
tor–bound protein 2 (Grb2), the Casitas B–lineage lymphoma
(Cbl) E3 ligase was recruited, leading to decreased NoxO1 sta-
bility and a subsequent reduction in ROS generation upon epi-
dermal growth factor (EGF) stimulation. Additionally, we show
that EGF-mediated phosphorylation ofNoxO1 induced its release
from Grb2 and facilitated its association with Nox activator 1
(NoxA1) to stimulate ROS production. Consistently, overexpres-
sion of Grb2 resulted in decreased Nox1 activity, whereas knock-
down of Grb2 led to increased Nox1 activity in response to EGF.
CRISPR/Cas9-mediated NoxO1 knockout in human colon cancer
cells abrogated anchorage-independent growth on soft agar and
tumor-forming ability in athymic nude mice. Moreover, the
expression and stability of NoxO1 were significantly increased
in human colon cancer tissues compared with normal colon.
Taken together, these results support a model whereby Nox1
activity and ROS generation are regulated by Grb2/Cbl-mediated
proteolysis of NoxO1 in response to EGF, providing new insight
into the processes by which excessive ROS production may
promote oncogenic signaling to drive colorectal tumorigenesis.
Cancer Res; 76(4); 855–65. 2016 AACR.
Introduction
It is firmly established that coupling of NADPH oxidase (Nox)
activitywith receptor signaling stimulates the transient generation
of reactive oxygen species (ROS), which function as a second
messenger in cell signaling (1–5). However, uncontrolled ROS
generation through the pathophysiologic state of mitochondria
or through hyperactivation of Nox results in cytotoxic damage to
intracellularmolecules, including lipid, DNA, andproteins (3–5).
Therefore, ROS generation by Nox isozymes should be tightly
regulated.
It has long been proposed that phosphorylation of regulatory
proteins inNox2 complex identified fromphagocytic cells such as
neutrophils and macrophages plays an important role in mod-
ulating Nox2 activity (6). Nox2 as a catalytic protein requires
integral protein p22phox and three cytosolic proteins: p47phox,
p67phox, and Rac. In the resting stage, p47phox is maintained as
an inactive form resulting from the intramolecular interaction of
two SH3 domains with the autoinhibitory region (AIR). Upon
stimulation of epidermal growth factor (EGF), phosphorylation
of p47phox by protein kinase C (PKC) results in exposure of the
tandem SH3 domain in the central region of p47phox for inter-
action with the proline-rich region (PRR) domain of p22phox and
one PRR in the COOH-terminal region of p47phox for the
binding to the SH3 domain of p67phox, leading to the activation
of the Nox2 complex. Since the identification of Nox1 from the
colon epithelium (7, 8), Nox activator 1 (NoxA1) as a homolog of
Nox2 regulatory proteins p67phox and Nox organizer 1 (NoxO1)
as a homolog of p47phox have been reported. Adaptor protein
NoxO1 contains two SH3 domains in the central region for
interaction with the PRR domain of p22phox and one PRR in
the COOH-terminal region for binding to the SH3 domain of
NoxA1, respectively. It has generally been assumed that the Nox1
complex is constitutively active because a domain homologous to
the AIR domain of p47phox ismissing inNoxO1 (9, 10). However,
it has been reported that Nox1 activity is transiently increased in
response to various agonists, including EGF (11–16), suggesting
that an additionalmechanism is in operation for the regulation of
Nox1 activity.
Here, we show for the first time that proteasome-based degra-
dation of NoxO1 regulates the integrity and activity of the
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Nox1–NoxA1–NoxO1 complex. Specifically, NoxO1 interacts
with Grb2, which in turn recruits Cbl, leading to ubiquitination
and degradation of NoxO1. We also demonstrate that EGF
induces NoxO1 release fromGrb2–Cbl and that the consequently
increased NoxO1 protein level leads to an additional active




HEK293T (human embryonic kidney cells) and HCT116
(human colorectal carcinoma cells) were obtained from the
ATCC.HEK293TandHEK293 stably expressingNox1 (designated
HEK293-Nox1; ref. 12) were maintained at 37C under an atmo-
sphere of 5% CO2 in culture dishes containing Dulbecco's Mod-
ified Eagle's Medium (JBI) supplemented with 10% fetal bovine
serum (FBS; JBI) and 1% antibiotic–antimycotic solution (Invi-
trogen Life Technologies). HCT116 cells were cultured under the
same condition with the exception of using RPMI-1640 medium
supplemented with 10% FBS and 1% antibiotic–antimycotic
solution.
Assay of intracellular H2O2 production
Intracellular H2O2 production was assayed after stimulation of
cells with EGF (100 ng/mL) for 3 minutes. Confluent cells were
washed with Hank's Balanced Salt Solution and incubated for 15
minutes with 5 mmol/L of Peroxy Orange-1 (PO-1) in the dark at
37C. PO-1 is oxidized by H2O2 to the brightest fluorescence.
After being washed with PBS, the cells were then examined with a
laser scanning confocal microscope (LSM510; Zeiss) equipped
with an argon laser tuned to an excitation wavelength of 540 nm
and a Zeiss Axiovert objective lens. Images were digitized and
stored at a resolution of 512 by 512 pixels. Five groups of cells
were randomly selected from each sample, and the mean relative
fluorescence intensity for each group of cells wasmeasured with a
Zeiss vision system and then averaged for all groups. All experi-
ments were repeated at least three times.
NoxO1 knockout HCT116 cell lines
Human HCT116 colon cancer cells were maintained in
McCoy's 5A Medium supplemented with 10% FBS. CRISPR/
Cas9-mediated genome modification was used to generate
NoxO1 knockout cells according to the manufacturer's protocol
(ToolGen Genome Engineering; refs. 17, 18).
Soft agar colony formation assay
To examine anchorage-independent growth, a cell suspension
(2  104 cells) was suspended in 0.4% agar in growth medium
and seeded in triplicate on 60-mm dishes precoated with 0.8%
agar in growth medium and incubated at 37C, 5% CO2. After 14
days, colonies were photographed and counted in four randomly
chosen fields and expressed as means of triplicates, representative
of two independent experiments (19).
Animal experiments
Tumors were formed by subcutaneous inoculation of HCT116
colon cancer cells (1  106 cells) into the right flank of athymic
Balb/c female nudemice (5 weeks of age; Orient). Tumor size was
measured with a caliper (calculated volume ¼ shortest diameter2
 longest diameter/2) at 2-day intervals. This study was reviewed
and approved by the Institutional Animal Care and Use Com-
mittee of Center for Laboratory Animal Sciences, Medical
Research Coordinating Center, HYU industry–University Coop-
eration Foundation.
Clinicopathologic characteristics of colorectal cancer patients
Colorectal cancer tissue samples were obtained from the
archives of the Department of Pathology, Yonsei University
(Seoul, Korea) and from theCancer Specimen Bank of theNation-
al Research Resource Bank Program of the Korea Science and
Engineering Foundation of the Ministry of Science and Technol-
ogy.Colon cancer tissueswere subjected to immunohistochemical
analysis with antibody against NoxO1 (Life Span BioScience Inc.).
Authorization for the use of these tissues for researchpurposeswas
obtained from the Institutional ReviewBoard of Yonsei University
of College of Medicine (IRB number 4-2012-0026). Colorectal
cancer tissue samples from 222 patients with primary colorectal
cancers of stages I to IV were used in this study. All patients had
undergone colorectal resection between 2004 and 2006.
Detailed information on mass spectrometry, site-directed
mutagenesis of NoxO1, small interfering RNA for Grb2, ubiqui-
tination assay, and NoxO1 knockout HCT116 cell lines are
described in the Supplementary Methods.
Results
Identification of Grb2 as a binding partner for NoxO1
To isolate candidate proteins with a regulatory effect on Nox1
complex, GST-NoxO1 pulldown assays were carried out using
HEK293 cell lysates. NoxO1 binding proteins were subjected to
tandem mass spectrometry (MS/MS) analysis for peptide
sequencing, leading to identification of Grb2 as a binding partner
for NoxO1 (Fig. 1A; Supplementary Fig. S1). Subsequently, we
verified interaction of NoxO1 with Grb2 using coimmunopreci-
pitation analysis. HEK293T cells were transfected with HA-tagged
NoxO1 together with or without FLAG-tagged Grb2. Immuno-
precipitation with antibody against HA confirmed that NoxO1
binds to Grb2 (Fig. 1B). To determine the functional domain of
Grb2 that interacts with NoxO1, we performed a yeast two-
hybridization assay. The assay showed that the SH3 domain of
Grb2 interacted with NoxO1 (Supplementary Fig. S2A). Next, we
used an immunoprecipitation assay to show that the carboxyl
terminal PRR domain of NoxO1 was required for the interaction
with Grb2 (Supplementary Fig. S2B). To evaluate the role of Grb2
in intracellular H2O2 generation via regulation of Nox1 activity,
Flag-taggedGrb2was transfected intoHEK293 cells stably expres-
sing Nox1 (HEK293-Nox1) as well as NoxA1 and NoxO1, and
intracellular H2O2 generation in response to EGF was measured.
In these experiments, we used boronate compound PO-1 dye,
which is specific to H2O2. Interestingly, increasing the amount of
ectopic Flag-tagged Grb2 resulted in decreased intracellular EGF-
induced H2O2 generation (Fig. 1C and 1E). In contrast, knock-
down of Grb2 by RNA interference led to increased intracellular
H2O2 generation in response to EGF (Fig. 1D and 1F). These
results suggested that Grb2 is involved in the negative regulation
of Nox1 activity.
Interaction of NoxO1 with the Grb2–Cbl complex results in its
degradation
It has been well established that apart from its role as a positive
regulator in the RTK–Ras–MAPK pathway, Grb2 functions as a
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Interaction of NoxO1 with Grb2. A, GST-NoxO1 was incubated with HEK 293 cell lysates and protein complex was subjected to SDS-PAGE. B, HA-tagged NoxO1 was
transiently expressed in HEK293T cells with FLAG-tagged Grb2. Cell lysates were immunoprecipitated with antibody to HA and subjected into immunoblotting
with antibody to FLAG or Grb2. C, HEK293-Nox1 cells were transfected with increasing amounts of FLAG-tagged Grb2 in the presence of HA-tagged NoxA1
and NoxO1. EGF-induced ROS generation was monitored by confocal microscopic analysis of DCF fluorescence. D, HEK293-Nox1 cells were transfected with
small interfering RNA for Grb2 or control siRNA in the presence of HA-tagged NoxA1 and NoxO1. ROS generation in response to EGF was monitored by
confocal microscopic analysis of DCF fluorescence. Data in C and D represent three repeated experiments and are shown as mean  SD (n ¼ 3). E, HEK293-Nox1
cells were transfected with increasing amounts of FLAG-tagged Grb2 in the presence of HA-tagged NoxA1 and NoxO1. F, HEK293-Nox1 cells were transfected
with small interfering RNA for Grb2 or control siRNA in the presence of HA-tagged NoxA1 and NoxO1. Expression of NoxA1, NoxO1, and Grb2 was analyzed by
immunoblotting with antibody to HA or FLAG (E and F).
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negative modulator of receptor-mediated signaling by recruiting
Cbl E3 ligase andpromoting receptor ubiquitination (20–22).We
hypothesized that the Grb2–Cbl complex interacts with NoxO1
and thereby regulates Nox1 activity. To verify the tertiary complex
formation, HEK293T cells were transfected with FLAG-Grb2 and
HA-NoxO1 and were examined in the coimmunoprecipitation
experiment with antibodies against FLAG or Cbl. Immunoblot-
ting clearly showed that Grb2 simultaneously interacted with
NoxO1 as well as endogenous Cbl (Fig. 2A). To evaluate the
function of Cbl inmodulating protein levels ofNox1,NoxA1, and
NoxO1, a Cbl-expressing plasmid was transfected into HEK293
cells expressing Nox1, NoxA1, or NoxO1. Overexpression of Cbl
had no effect on protein levels of Nox1 and NoxA1 (Supplemen-
tary Fig. S3). However, NoxO1 protein was significantly destabi-
lized by Cbl in a dose-dependent manner, and this degradation
was completely blocked by pretreatment with the proteasome
inhibitor MG132 (Fig. 2B). Next, we explored whether NoxO1
ubiquitination was dependent on Cbl activity. Transfection of
wild-type Cbl into HEK293T cells resulted in significantly
increased polyubiquitination of NoxO1, whereas NoxO1 ubiqui-
tination was inhibited in the presence of C3AHN E3 ligase–
defective RING mutant of Cbl (Fig. 2C; ref. 23). The result
indicated that NoxO1 protein is ubiquitinated by Cbl as its
specific E3 ligase. Because p47phox in the Nox2 complex is the
homolog of NoxO1 in the Nox1 complex, we also analyzed the
ubiquitination of p47phox by Cbl. In contrast with NoxO1, over-
expression of Cbl failed to ubquitinate p47phox, indicating that
Cbl-mediated ubiquitination is not a regulatory mechanism of
Nox2 complex (Supplementary Fig. S4A).
To examine the effect of Cbl-dependent NoxO1 degradation
on EGF-induced H2O2 generation, we used HCT116 colon
carcinoma cells, which endogenously express NoxA1 and
NoxO1 as well as Nox1. Stimulation of HCT116 cells with
EGF resulted in increased NoxO1 protein levels coinciding with
the rapid generation of intracellular H2O2 (Fig. 2D and 2E).
Pretreatment of HCT116 cells with MG132 demonstrated an
increased basal level of NoxO1 protein compared with control
cells (Fig. 2D). The kinetics of NoxO1 expression matched that
of intracellular H2O2 generation in response to EGF in the
presence of MG132 (Fig. 2D and 2E). However, the mRNA level
of NoxO1 did not change in HCT116 cells in response to EGF
(Supplementary Fig. S4B). These results strongly indicated that
NoxO1 protein in the resting stage is maintained at a low level
through Cbl-dependent degradation and that upon stimulation
with EGF, NoxO1 degradation is inhibited, leading to a sus-
tained high level of NoxO1 expression and intracellular H2O2
generation.
PhosphorylationofNoxO1 inducesGrb2 release and formation
of active Nox1 complex
We next questioned whether the interaction of NoxO1 with
Grb2 was regulated by EGF. Using HEK293-Nox1 cells expressing
HA-NoxO1 and FLAG-Grb2, we observed that the NoxO1–Grb2
interaction decreased in response to EGF stimulation and recov-
ered 20 minutes after the initial exposure to EGF (Fig. 3A). The
result suggested that interaction of NoxO1 with Grb2 is transient-
ly abrogated by exposure to EGF. To investigate the interaction
between endogenous NoxO1 and Grb2 in HCT116 cells, we
performed a coimmunoprecipitation experiment with antibody
against Grb2 and then immunoblotted with antibody to NoxO1.
Stimulation of HCT116 cells with EGF resulted in reduced inter-
action of Grb2 with NoxO1 in the coimmunoprecipitated com-
plex and a concomitant increased endogenous NoxO1 stability in
total cell lysate (Fig. 3B).
It has been recently reported that phosphorylation of serine154
on NoxO1 by PKC plays an important role in Nox1 complex
formation (24). To validate PKC-dependent NoxO1 stability,
staurosporine as a PKC inhibitor and PMA as a PKC activator
were applied in analyses of association of NoxO1 with Grb2 and
NoxO1 stability. Pretreatment of staurosporine resulted in asso-
ciation of NoxO1 with Grb2 in response to EGF, whereas EGF or
PMA alone stimulated the dissociation of the complex (Supple-
mentary Fig. S5A). Moreover, pretreatment of staurosporine
showed suppressed ROS generation and stability of NoxO1 in
response to EGF (Supplementary Fig. S5B). In contrast, incuba-
tion of PMA led to increased stability of NoxO1 (Supplementary
Fig. S5C). These results indicate that activation of PKC is involved
in NoxO1 stability and ROS generation in response to EGF.
Consistently, while dissociation of wild-type NoxO1 from Grb2
was facilitated in response to EGF,NoxO1 S154Amutant failed to
show a similar response (Fig. 3C).
It is well known that the association of another cytosolic
regulator NoxA1 to NoxO1 is required for the formation of an
active Nox1 complex (1, 4, 7).We duly showed that interaction of
NoxO1 with Grb2 was inhibited in the presence of an increasing
amount of NoxA1 (Fig. 3D). To test the binding preference of
NoxO1 to either Grb2 or NoxA1, GFP-NoxO1, HA-NoxA1, and
Flag-Grb2 were transfected into HEK293-Nox1 cells. Interaction
of NoxO1 with Grb2 was decreased in response to EGF stimula-
tion, whereas binding of NoxO1 to NoxA1 was reciprocally
increased (Fig. 3E). This shift in the binding preference of NoxO1
by EGF stimulation indicated that NoxA1 plays a crucial role in
protecting NoxO1 from Grb2, leading to the formation of an
active Nox1 complex for ROS generation.
Next, we investigated the effect of Grb2 knockdown on
membrane translocation of NoxO1 and NoxA1 as an indication
of Nox1 complex formation in response to EGF. Silencing of
Grb2 expression by transfection of siRNA specific to Grb2
(siGrb2) in HCT116 cells failed to induce enhanced EGF-
dependent membrane translocation of NoxO1 and NoxA1
compared with control siRNA-transfected cells (siCon; Supple-
mentary Fig. S6A). We also tested EGF-dependent membrane
translocation of NoxO1 S154A mutant in HEK293 cells.
NoxO1 S154A mutant led to decreased membrane transloca-
tion in response to EGF compared with wild-type NoxO1.
Expression of NoxO1 S154A mutant failed to induce mem-
brane translocation of NoxA1 in response to EGF (Supplemen-
tary Fig. S6B). These results indicated that phosphorylation of
serine154 of NoxO1 is essential for the interaction of NoxO1
with Grb2 and membrane translocation of NoxO1.
Deficiency of NoxO1 attenuates tumor growth of HCT116 cells
Several recent reports indicate that intracellular ROS gener-
ation by the Nox1 complex appears to play an important role in
cellular transformation (25, 26). To evaluate the function of
NoxO1 in Nox1-mediated ROS generation and cellular trans-
formation, we attempted NoxO1 knockout from HCT116 cells
using CRISPR/Cas9-mediated genome modification (17, 18).
We established multiple NoxO1 knockout cell lines, from
which we selected three for further experiments: NoxO1-KO1
(40-bp deletion/1-bp insertion), NoxO1-KO4 (1-bp deletion/
166-bp insertion), and NoxO1-KO5 (56-bp deletion/93-bp
Joo et al.
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Ubiquitin-dependent proteosomal degradation ofNoxO1. A, Grb2 interactionwith Cbl aswell asNoxO1. HA-taggedNoxO1was transiently expressed inHEK293T cells
with FLAG-taggedGrb2. Cell lysateswere immunoprecipitatedwith antibody to FLAG and subjected to immunoblottingwith antibody toHA or Cbl. B, HEK293-Nox1
cells were transfected with increasing amounts of expression vector for Cbl in the presence of NoxO1. Cells were treated with 0.5 mmol/L MG132 for 6 hours.
Total cell lysates were subjected to immunoblot analysis with antibody to HA. C, HA-tagged wild-type Cbl (WT) or mutant Cbl (C3AHN) was transiently expressed
with combination of FLAG-taggedNoxO1 andMyc-tagged ubiquitin (Ub) in HEK293T cells as indicated. Cellswere treatedwith 2mmol/LMG132 for 12 hours. Total cell
lysates were subjected to immunoprecipitation with antibody to FLAG, and the resulting precipitates were subjected to immunoblot analysis with antibodies
against FLAG, HA, or Myc. D, effect of MG132 on ROS generation in response to EGF stimulation in HCT116 cells. EGF-induced ROS generation was monitored by
confocal microscopic analysis of DCF fluorescence. E, the expression level of endogenous NoxO1 in EGF-stimulated HCT116 cells was analyzed by immunoblotting
with antibody to NoxO1. HCT116 cells were pretreated with 0.5 mmol/L MG132 for 6 hours and cell lysates were subjected to immunoblotting with antibody to NoxO1.
Data (A–E) represent three repeated experiments and are shown as mean  SD (n ¼ 3).
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EGF induces NoxO–NoxA1 interaction. A, effect of EGF stimulation on the interaction between NoxO1 and Grb2. HA-tagged NoxO1 was transiently expressed in
HEK293T cells with FLAG-tagged Grb2 as indicated. Total cell lysates were immunoprecipitated with antibody to HA and subjected to immunoblotting with
antibody to HA or FLAG. B, endogenous complex of NoxO1 with Grb2 in HCT116 cells. HCT116 cells were treated with EGF for 5 minutes and cell lysates
were then subjected to immunprecipitation with antibody to Grb2. Immunoprecipitated complex was subjected to immunoblotting with antibodies to NoxO1,
Grb2, or actin. C, FLAG-tagged wild-type NoxO1 (WT) or mutant NoxO1 (S154A) was transiently expressed in HEK293-Nox1 cells as indicated. After
stimulation with EGF, total cell lysates were then immunoprecipitated with anti-FLAG antibody, followed by immunoblotting with anti Grb2, anti-FLAG
antibody. D, effect of NoxA1 on the interaction of NoxO1 with Grb2. HEK293-Nox1 cells were transfected with increasing amounts of HA-tagged NoxA1 in the
presence of FLAG-tagged Grb2 and GFP-tagged NoxO1. Total cell lysates were subjected to immunoprecipitation with antibody to FLAG, and the resulting
precipitates were subjected to immunoblot analysis with antibodies against GFP, FLAG, and HA. E, effect of EGF on the interaction between NoxO1 and
Grb2 or NoxA1. HEK293-Nox1 cells were transfected with HA-tagged NoxA1, FLAG-tagged Grb2, and GFP-tagged NoxO1. Total cell lysates were subjected to
immunoprecipitationwith antibody toGFP antibody, and the resultingprecipitateswere subjected to immunoblot analysiswith antibodies against HA, FLAG, orGFP.
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deletion). Deletion of NoxO1 was confirmed by an immuno-
blot assay with antibody against NoxO1. Expression of NoxO1
in the three cell lines was completely ablated (Fig. 4A). Impor-
tantly, stimulation of the three cell lines with EGF failed to
generate ROS, compared with control cells (Fig. 4B). To exam-
ine the effect of NoxO1 on tumorigenic capacity of HCT116
cells and the three cell lines (NoxO1-KO1, NoxO1-KO4, and
NoxO1-KO5), we first analyzed cell proliferation as measured
by trypan blue exclusion assay (Fig. 4C). The growth rate of
wild-type HCT116 cells was higher than three NoxO1 KO
HCT116-mutant cells (Fig. 4C).
We wondered if the lack of NoxO1 in the three HCT116
derivative cell lines would free up Grb2 and lead to additional
stimulation of the EGF signaling pathway. We examined Erk
phosphorylation as a measure of EGFR–Ras pathway activation.
Indeed, stimulation of three NoxO1 knockout HCT116 cells with
EGF resulted in significantly increased Erk phosphorylation com-
pared with wild-type HCT116 cells (Supplementary Fig. S7A).
Pretreatment of MG132 as a proteasome inhibitor did not affect
Erk phosphorylation in HCT116 cells (Supplementary Fig. S7B).
However, three NoxO1 knockout HCT116 cells showed lower
ROS generation and growth rate than wild-type HCT116 cells,
consistent with the role of ROS in cell proliferation (Fig. 4B and
4C). This represents a paradox of a kind as RAS–Erk signaling is
apparently activated but proliferation is retarded. We examined
the possibility that cell apoptosis in three NoxO1 knockout
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NoxO1 is a critical regulator for tumor
growth in HCT116. A, immunoblotting of
NoxO1 and actin in HCT116 cells and three
NoxO1 knockout cell lines (NoxO1-KO1,
NoxO1-KO4, and NoxO1-KO5). B, ROS
generation was monitored by confocal
microscopic analysis of DCF in EGF
stimulated cells. Data represent three
repeated experiments and are shown as
mean  SD (n ¼ 3). C, effect of NoxO1
expression on HCT116 cell growth. Data
represent three repeated experiments
and are shown as mean  SD (n ¼ 3).
D, soft agar assay with wild-type cells or
three NoxO1 knockout HCT116 cell lines.
Data represent three repeated
experiments and are shown asmean SD
(n ¼ 3). E, soft agar assay with wild-type
cells or three NoxO1 knockout HCT116 cell
lines. Data represent three repeated
experiments and are shown asmean SD
(n ¼ 3). F, tumor growth curves of
xenografts derived from HCT116 cells or
three NoxO1 knockout HCT116 cell lines.
Graph shows that tumor size of athymic
nude mice derived from HCT116 cells
(N ¼ 7) or three NoxO1 knockout HCT116
cell lines (NoxO1-KO1, N ¼ 7; NoxO1-KO4,
N ¼ 7; and NoxO1-KO5, N ¼ 5). G, tumor
growth of xenografts derived fromHCT116
cells or three NoxO1 knockout HCT116 cell
lines after 35 days of injection.
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HCT116 cells is enhanced. Populations of apoptotic cells in three
NoxO1 knockout HCT116 cells were higher in proportion than in
wild-type cells (Supplementary Fig. S7C). Several studies reported
that scavenging of ROS by addition of antioxidant chemical
compounds or proteins leads to cell death (27–32). Taken togeth-
er, our data indicate that a concerted action of two signaling
cascades, Nox-dependent ROS generation and ROS-independent
signaling event such as Erk phosphorylation, plays an important
role in cell growth.
We next performed an anchorage-independent colony forming
assay. Notably, knockout of NoxO1 (NoxO1-KO) drastically
suppressed the anchorage-independent colony forming ability of
HCT116 colon cancer cells (Fig. 4D and 4E). To confirm this result
in vivo, we injectedHCT116 cells as a control and threeNoxO1-KO
derivative cell lines (NoxO1-KO1, NoxO1-KO4, and NoxO1-
KO5) subcutaneously into the right flank of athymic nude mice.
In agreement with the in vitro data, tumor formation was signif-
icantly retarded in xenograft mice injected with NoxO1-depleted
HCT116 colon cancer cells comparedwith the control group (Figs.
4F and G). Taken together, these results suggest that NoxO1 is a
critical regulator for tumor formation in HCT116 cancer cells.
High NoxO1 stability provides a basis of ROS-contributed
development of colon cancer
Since Nox1 was first identified from colon epithelium, sev-
eral reports suggested that Nox1-mediated ROS generation is
involved in chronic inflammation of the epithelium and devel-
opment of colorectal cancer (25, 33, 34). We thus questioned
whether NoxO1 stability was increased in colorectal cancer
cells. Cell lysates from colorectal cancer and adenoma tissues
of 12 independent patients were subjected to immunoblot
analysis with antibody to NoxO1. The NoxO1 protein level
was significantly increased in colorectal cancer tissues com-
pared with normal tissues (Fig. 5A and B). We next investigated
NoxO1–Grb2–Cbl tertiary complex formation in the normal
colon tissues and tumor tissues. NoxO1 stability was an
increase in whole-cell lysate of colon cancer tissues (Fig. 5C).
While the protein complex isolated with the antibody to Grb2
from normal tissues contained NoxO1 and Cbl, the complex
from colon cancer tissues were negative for these proteins (Fig.
5C). The result indicated that the NoxO1–Grb2–Cbl complex is
disrupted in growing cancer tissues. To investigate interaction
of the endogenous NoxA1/NoxO1/p22phox/Nox1 complex in
cancer tissues, we performed a coimmunoprecipitation exper-
iment with antibody against NoxA1 and then immunoblotting
with antibodies to NoxO1, p22phox, or Nox1. Complex of
NoxA1 with NoxO1/p22phox/Nox1 was increased in amount
in cell lysate in cancer tissues compared to normal tissues
(Supplementary Fig. S7D). We next investigated Erk phosphor-
ylation in the normal colon tissues and tumor tissues. The
level of Erk phosphorylation was increased in the cell lysate of
colon cancer tissues compared with normal control tissues
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High stability of NoxO1 in colon cancer
tissues. A, immunoblotting of NoxO1 and
actin in human colon cancer tissues (T),
and matched nontumorous colonic
mucosal tissues (N; top), or human colon
cancer tissues (T), and matched
adenocarcinoma mucosal tissues and
matched nontumorous colonic mucosal
tissues (N; bottom). B, expression of
NoxO1 in NoxO1-positive colon cancer
tissues (T, n ¼ 12) compared with
nontumorous colonic mucosal tissues
(N, n ¼ 12) by immunoblotting of NoxO1
and actin in T, and matched N. Statistical
analysis was conducted with a paired
t test (P<0.05). C, cell lysates fromnormal
and colon cancer tissues were
immunoprecipitated with antibody to
Grb2 and subjected to immunoblotting
with antibody to NoxO1, Grb2, or Cbl.
D, immunohistochemical analysis of
NoxO1 protein expression in colon cancer
tissues. E, the amount of NoxO1
expression was analyzed by using the
ImageJ program.
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(Supplementary Fig. S7E). These results are consistent with the
hypothesis that both of Nox-dependent ROS generation
and ROS-independent signaling through Erk phosphorylation
likely contribute to cell proliferation.
We also evaluated the NoxO1 protein level in 222 colorectal
cancer tissues by immunohistochemistry. NoxO1 expression
was hardly detected in normal tissue areas in virtually all
samples, whereas the expression was readily detected in the
cytoplasm of colorectal cancer cells again virtually in all cases
(Fig. 5D and E). The expression of NoxO1 in normal (n ¼ 184)
and colorectal cancer tissues (n¼ 222) was reevaluated with the
ImageJ program and categorized as positive and negative. The
intensities of positive NoxO1 expression cases (n ¼ 159) were
significantly higher than those of negative NoxO1 expression
cases (n ¼ 63; Fig. 5E). Moreover, all pathological stages in
positive NoxO1 expression cases expressed NoxO1 at high
levels, suggesting that increased NoxO1 stability is correlated
with early developmental stages of colorectal cancer (Supple-
mentary Table S1). It has been well established that Ras
mutation plays an important role in tumorigenesis in a large
proportion of colorectal cancer cases (35). To investigate the
relationship between Ras mutations and ubiquitin-dependent
proteolysis of NoxO1, we used cell lines expressing wild-type
(RKO and HK29) or K-Ras G13D mutant (HCT116 and DLD).
Increasing NoxO1 stability by EGF in cancer cell lines expres-
sing K-Ras G13D mutant was qualitatively similar to that seen
in cells expressing wild-type K-Ras (Supplementary Fig. S7F).
This result suggests that increased NoxO1 expression in cancer
cells is independent of Ras signaling.
Discussion
It has been well established that controlled and moderated
levels of ROS play an important role in cell signaling, growth,
differentiation, apoptosis, and motility, whereas uncontrolled
and excessive levels of ROS lead to unexpected cytotoxic damage
and cell death contributing to thedevelopment of various diseases
such as atherosclerosis, autoimmune disorders, neuronal degen-
eration, and cancer (36–40). The notion that uncontrolled gen-
eration of ROS through hyperactivation of Nox isozyme induces
pathologic stages indicates that tight regulatory mechanisms for
Nox isozymes must be provided in cells or tissues. One well-
established regulatory mechanism for various Nox complexes is
phosphorylation of regulatory proteins such as p47phox. In the
case of Nox1, however, it has been proposed that no such
regulation exists. This was mainly based on that NoxO1 protein
lacks AIR region, the target of phosphorylation.
We here provide a novel mechanism for regulation of Nox1
activity involving ubiquitination and degradation of NoxO1
(Fig. 6). Specifically, the Cbl-mediated proteolytic pathway
results in negative regulation of ROS generation by Nox1 via
ubiquitination and degradation of NoxO1. The rapid degrada-
tion of NoxO1 is inhibited by serine 154 phosphorylation of
NoxO1, leading to dissociation of NoxO1 from Grb2–Cbl and
subsequent association with NoxA1 (Fig. 6). In contrast with
NoxO1, stability of p47phox was not affected by Cbl over-
expression (Fig. S4A). It is likely that key regulation of p47phox
is mediated by phosphorylation of the AIR region rather than
the ubiquitination pathway. Recently, Noubade and colleagues
Figure 6.
Proposed mechanism of Nox1 regulation by ubiquitination of NoxO1. In the resting state, NoxO1 is rapidly degraded by Cbl-mediated ubiquitination. Stimulation
of EGF results in increased NoxO1 stability, leading to formation of an active Nox1 complex for ROS generation. After the peak of ROS generation, interaction
between 14-3-3 and phosphorylated NoxA1 disintegrates the active Nox1 complex for the desensitization of ROS generation. ROS level subsequently
returns to the basal state.
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(41) reported that a negative regulator of ROS (NRROS) direct-
ly interacts with Nox2 and stimulates its degradation through
the proteasome-dependent ER-associated degradation (ERAD)
pathway. Degradation of Nox2 was rescued by p22phox, which
resulted in stable complex formation of Nox2-p22phox and
then sufficient ROS generation for host defense. Moreover, it
has been recently reported that HECT domain and Ankyrin
repeat containing E3 ubiquitin protein ligase 1 (HACE1) reg-
ulate Nox1 activity through the degradation of active Rac1 (42).
HACE1-dependent active Rac1 degradation signifies the turn-
ing-off of ROS signaling in response to growth factor.
Nox-mediated ROS has been implicated in cell growth and
survival (25). Promitotic effect of Nox-mediated ROS could be
deduced from the transient inactivation of protein tyrosine phos-
phatase through the oxidation of redox-sensitive cysteine residue
in the active center (43–46). The balance betweenprotein tyrosine
phosphatase and kinase was shifted to enhanced kinase activity,
leading to activation of transcriptional factors and increased
expression of EGFR for autonomous cell growth and survival
(45–47). Proinflammatory cytokines such as TNFa and TRAIL in
various cancer cells induce the increased Nox1 and NoxO1
expression, suggesting that Nox1 and its accessory protein expres-
sion are regulated at the transcriptional level in cancer cells (48,
49). These reports suggest that sequential activation of EGF-
mediated cell signaling cascades including ROS generation
induces transcriptional activation of NoxO1 cancer cells. Consis-
tently, a large portion of colon cancer patients (up to 70%)
showed increasedNoxO1 expression.Whether the transcriptional
activation ofNoxO1 in colorectal cancer results from activation of
Nox1 via a positive feedback loop involving an autocrine requires
further investigation (Fig. 5). Moreover, a previous study reported
that deficiency of Nox1 is involved in sequential inactivation of
PI3K/Akt/Wnt/b-catenin/Notch cascades, leading to control of
the cell fate choice of proliferative colonic epithelial cells over
post-mitotic goblet cells (34). Therefore, increased NoxO1 sta-
bility in colorectal cancer should induce Nox1-mediated ROS
generation, which would in turn result in proliferation of colonic
epithelial cells and contribute to colorectal tumorigenesis and the
progression of cancer.
In summary, we describe a novel mechanism for regulation of
functional Nox1 complex formation based on Cbl-mediated
ubiquitination of NoxO1, which in turn is demonstrated to be
negatively modulated by EGF signaling, leading to increased
synthesis of ROS (Fig. 6). Moreover, high NoxO1 stability in the
Nox1 complex provides a basis for the ROS-contributed devel-
opment of colon cancer.
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